16Dec 2017

ONE CASE OF REFRACTORY STATUS EPILEPTICUS AND AUTOIMMUNE ENCEPHALITIS.

  • Head of Department of critical care., university central clinic after acad. N. Kipshidze ,MD, PhD. Prof.of TSMU (Tbilisi, Georgia).
  • Neurologist, Md, PHD (Tbilisi, Georgia).
Crossref Cited-by Linking logo
  • Abstract
  • References
  • Cite This Article as
  • Corresponding Author

Purpose: Encephalitis is a severe inflammatory disorder of the brain with many possible causes and with difficult differentiate of diagnosis. Existing criteria for autoimmune encephalitis are too reliant on antibody testing and response to immunotherapy, which might delay the diagnosis. Several particular features raise the suspicion of an autoimmune cause in otherwise unexplained seizure disorders. One of the most important challenges is the elucidation of the causes of seizure disorders. We presented one case of unexplained coma and refractory status epilepticus. Patient, 20 yars old.men, was admetted in hospital with coma , stable hemodinamics, on mechanical ventilation. On MRI research was discovered existence of inflammatory infiltration.At primery stage , EEG- discovered polymorphic dysrhythmia,bilateral activity,than plural peak shurp-slow wave paroxysms and status epilepticus. It was conducted combinated treatment with anticonvulsive drugs ,Immunoglobulin, pulse corticosteroid therapy with methylprednizolone and plazma exchange therapy. Conclusion: An autoimmune cause was suspected based on frequent or medically intractable seizures and the presence of neural antibody, inflammatory changes indicated in spinal fluid and on MRI. Patients had abnormal findings on brain MRI, with extensive multifocal or diffuse cortical and subcortical involvement. EEG showed generalized periodic discharges and status epilepticus . within investigation of IgG autoantibodies against proteins on the surfaces of neurons, we received difference result from two different laboratory,but refractory status epilepticus,radiological changes ,EEG pattern and progress of illness has indicated autoimmune character of process.


  1. Hocker S, Tatum WO, LaRoche S, Freeman WD. Refractory and super-refractory status epilepticus?an update. Curr Neurol Neurosci Rep 2014;14:452.
  2. Hunter G, Young B. Status epilepticus: a review, with emphasis on refractory cases. Can J Neurol Sci 2012;39:157?69.
  3. Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012;17:3?
  4. Borris DJ, Bertram EH, Kapur J. Ketamine controls prolonged status epilepticus. Epilepsy Res 2000;42:117?22.
  5. Tarocco A, Ballardini E, Garani G. Use of ketamine in a newborn with refractory status epilepticus: a case report. Pediatr Neurol 2014;51:154?6.
  6. Synowiec AS, Singh DS, Yenugadhati V, Valeriano JP, Schramke CJ, Kelly KM. Ketamine use in the treatment of refractory status epilepticus. Epilepsy Res 2013;105:183?8.
  7. Zeiler FA, Kaufmann AM, Gillman LM, West M, Silvaggio J. Ketamine for medically refractory status epilepticus after elective aneurysm clipping. Neurocrit Care 2013;19:119?24.
  8. Esaian D, Joset D, Lazarovits C, Dugan PC, Fridman D. Ketamine continuous infusion for refractory status epilepticus in a patient with anticonvulsant hypersensitivity syndrome. Ann Pharmacother 2013;47:1569?76.
  9. Kramer AH. Early ketamine to treat refractory status epilepticus. Neurocrit Care 2012;16:299?305.
  10. Irani SR, Bien CG, Lang B. Autoimmune epilepsies. Curr Opin Neurol2011;24:146?153
  11. Lee WJ, Lee ST, Byun JI, Sunwoo JS, Kim TJ, Lim JA, Moon J, Lee HS,Shin YW, Lee KJ, Kim S, Jung KH, Jung KY, Chu K, Lee SK. Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort. Neurology 2016;86:1683?1691.
  12. Bien CG. Value of autoantibodies for prediction of treatment response in patients with autoimmune epilepsy: review of the literature and suggestions for clinical management. Epilepsia 2013;54(suppl2):48?55.
  13. McKeon A, Lennon VA. NMDAR encephalitis: which specimens, and the value of values. Lancet Neurol 2014;13:133?135.
  14. Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L,Leypoldt F, Gleichman AJ, Balice-Gordon R, Rosenfeld MR, Lynch D,Graus F, Dalmau J. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 2014;13:167?177
  15. H?ftberger R, Dalmau J, Graus F. Clinical neuropathology practice guide 5-2012: updated guideline for the diagnosis of antineuronal antibodies. Clin Neuropathol 2012;31:337?341.
  16. DeSena AD, Noland DK, Matevosyan K, King K, Phillips L, Qureshi SS, Greenberg BM, Graves D. Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti-n-methyl-daspartate receptor antibody encephalitis: a retrospective review. JClin Apher 2015;30:212?216
  17. Christian G. Bien,1* Martin Holtkamp2 ?Autoimmune Epilepsy?: Encephalitis With Autoantibodies for Epileptologist ,Current Review , Clinical Science Epilepsy Centre Bethel, Krankenhaus Mara, Bielefeld, Germany,Epilepsy-Center Berlin-Brandenburg, Department of Neurology, Charit? ? Universit?tsmedizin Berlin, Berlin, Germanys,

[Guliko Kiliptari and Ia Rukhadze. (2017); ONE CASE OF REFRACTORY STATUS EPILEPTICUS AND AUTOIMMUNE ENCEPHALITIS. Int. J. of Adv. Res. 5 (Dec). 778-785] (ISSN 2320-5407). www.journalijar.com


Ia Rukhadze2
Head of Department of critical care. The First University Clinic, MD, PhD. Prof.of TSMU (Tbilisi, Georgia).

DOI:


Article DOI: 10.21474/IJAR01/6019      
DOI URL: https://dx.doi.org/10.21474/IJAR01/6019